This document summarizes the anatomy and physiology of the urinary bladder and urinary sphincters. It describes the neural pathways that control bladder filling and emptying from the cortical and subcortical areas down to the spinal cord and peripheral nerves. It then discusses various types of neurogenic bladder disorders that can result from lesions or injuries in different parts of the neural pathways.
This ppt describes various movement disorders found commonly in elderly persons. It also describes hyper and hypokinetic disorder categorization with cause and pathophysiology of movement disorders.
This ppt describes various movement disorders found commonly in elderly persons. It also describes hyper and hypokinetic disorder categorization with cause and pathophysiology of movement disorders.
These lecture notes were prepared by Dr. Hamdi Turkey- Pulmonologist- Department of internal medicine - Taiz university
Do Not Forget To Visit Our Pages On Facebook on the following Links:
https://www.facebook.com/groups/569435236444761/
AND
https://www.facebook.com/groups/690331650977113/
Approach to bladder symptoms, Innervation of Bladder, Control of Micturition, Bladder Functions, Funtions and synergy of Sphincters and Detrusor, UMN Bladder, LMN Bladder, Pathological Basis of symptoms, Clinical signs in different types of Bladder, Investigations of Bladder disorder, Approach to Treatment of bladder disorders,Clean Intermittent Self Catherterisation, Surgical Treatment of bladder dysfunction
Follow up and Complications
CONCEPT OF NODOPATHIES AND PARANODOPATHIES.pptxNeurologyKota
emergence of autoimmune neuropathies and role of nodal and paranodal regions in their pathophysiology.
Peripheral neuropathies are traditionally categorized into demyelinating or axonal.
dysfunction at nodal/paranodal region key for better understanding of patients with immune mediated neuropathies.
antibodies targeting node and paranode of myelinated nerves have been increasingly detected in patients with immune mediated neuropathies.
have clinical phenotype similar common inflammatory neuropathies like Guillain Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy
they respond poorly to conventional first line immunotherapies like IVIG
This presentation briefs out the approach of dementia assessment in line with consideration of recent advances. Now the pattern of assessment has evolved towards examining each individual domain rather than lobar assessment.
This presentation contains information about Dementia in Young onset. Also it describes the etiologies, clinical feature of common YOD & their management.
Entrapment Syndromes of Lower Limb.pptxNeurologyKota
This presentation contains information about the various Entrapment syndromes of Lower limb in descending order of topography. It also contains information about etiology, clinical features and management of each of these entrapment syndromes with special emphasis on electrodiagnostic confirmation.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
2. Bladder divided into
◦ Detrusor (aka as “body” or “dome” of bladder)-
consists of smooth muscle
◦ Base-trigone and bladder neck, intimately
connected to pelvic floor.
Bladder outlet-two urethral sphincters
◦ Internal (smooth muscle) sphincter-bladder neck
and proximal urethra
◦ External (striated muscle) sphincter-membranous
urethra.
Females-Less complex urinary sphincter
mechanism
3. Cortical control areas
In frontal and cingulate gyri as well as
subcortical areas
Provide inhibitory influence on micturition at
level of pons
Excitatory influence on external urinary
sphincter.
Allows voluntary control of micturition
Normal bladder evacuation can be delayed
until appropriate time and place to void are
chosen.
4. Pontine micturition center (PMC, Barrington’s
nucleus or M-region)
Locus ceruleus, pontomesencephalic gray
matter, nucleus tegmentolateralis dorsalis.
Essential for coordination of micturition.
Modulates opposing effects of
parasympathetic and sympathetic nervous
systems on lower urinary tract.
8. From T11- L2 cord level
Synapse in inferior mesenteric and hypogastric
plexuses
Continues via hypogastric nerves to α-adrenergic
receptors in bladder neck and proximal urethra,
β-adrenergic receptors in bladder fundus.
Also innervate parasympathetic ganglia in
detrusor wall.
Activation of thoracolumbar sympathetic
outflow-> norepinephrine release-> detrusor
relaxation and bladder neck (internal sphincter)
contraction
9. From detrusor nucleus (intermediolateral
column of gray matter) at S2–S4 cord level
Passes through pelvic nerves to cholinergic
parasympathetic neurons in ganglia in
detrusor.
Acetylcholine produces detrusor contraction
through M2 and M3 receptor
Proximal urethra-nitric oxide release->
urethral smooth muscle relaxation.
10. From pudendal (Onuf ’s) nucleus at S2–S4
cord level
Passes through pudendal nerve to external
sphincter.
Supraspinal Centers produce excitatory
influence on pudendal nucleus during bladder
filling stage to produce external urethral
sphincter and pelvic floor contraction to help
maintain continence,
11. Three mixed nerves innervate urinary tract.
Hypogastric nerve-sympathetic
Pelvic nerve-parasympathetic
Pudendal nerves-somatic nervous system
innervation.
12. Afferent information on state of bladder
filling-sensory fibers in dense suburothelial
and muscular plexuses.
Small myelinated Aδ fibers-distention and
trigger micturition
Unmyelinated C fibers-painful stimuli.
Pelvic nerves-> sacral dorsal root ganglia->
PAG region.
18. Sensory
◦ Damage to sensory fibers from bladder to spinal
cord
◦ No bladder sensation, eventual loss of motor
function
Motor
◦ Damage to motor fibers from spinal cord to bladder
◦ Normal sensation, failure of motor function
Uninhibited
◦ Injury to cortical regulation of bladder reflex
◦ Normal sensation and motor function, urge
incontinence, urinary frequency
19. Autonomous
◦ Damage to both motor and spinal fibers between
bladder and spinal cord
◦ Failure to generate bladder contraction, loss of
bladder sensation
Reflex
◦ Damage to spinal cord between sacrum and
brainstem
◦ Poorly coordinated bladder function, loss of
sensation, incontinence
20. Cortical lesions, such as intracranial bleed,
ischemic stroke, brain tumor, hydrocephalus.
Reduced awareness of bladder fullness and
low capacity bladder due to reduction of
inhibition of PMC by cortical and subcortical
structure damage.
No high bladder pressures developed.
Symptoms-urinary frequency, urgency, urge
urinary incontinence.
21. Urodynamic testing- normal bladder
sensation and filling parameters, multiple
unstable contractions
With an underlying neurologic-detrusor
hyperreflexia
With no known etiology-detrusor instability.
Detrusor overactivity,
22. Urinary storage symptoms (frequency, urgency,
urge urinary incontinence)-57% to 83%
Voiding symptoms (poor force of stream,
hesitancy, incomplete emptying)-17% to 27%
Urodynamic-detrusor hyperreflexia and urethral
sphincter bradykinesia.
Striated urethral sphincter-poorly sustained
contraction.
Symptoms of bladder outlet obstruction (BOO)-
should be confirmed by multichannel urodynamic
studies.
23. Degeneration of nucleus of Onuf
Denervation of external striated sphincter.
Sympathetic nerve atrophy-nonfunctional
bladder and an open bladder neck.
Urodynamic-detrusor hyperreflexia, few
individuals may have detrusor areflexia or
poorly sustained bladder contractions.
Bladder neck (internal sphincter)-open at
rest, with striated sphincter denervation.
24. Detrusor-sphincter dyssynergia (DSD)-
simultaneous detrusor and urinary sphincter
contractions produce high pressures in
bladder (up to 80–90 cm H2O)
Leads to vesicoureteral reflux
Lesions above T10 level
Detrusor overactivity, or detrusor
hyperreflexia
Activation of prejunctional M1 receptors
which facilitates acetylcholine release,
25. Spinal Cord Lesions
In acute lesion-spinal shock.
Anal and bulbocavernosus reflex typically absent.
Urinary retention and constipation.
Urodynamic-areflexic detrusor and rectum.
Internal and external urethral sphincter
activities-normal.
After spinal shock, bladder function returns.
detrusor activity increases in reflex excitability to
an overactive state—detrusor hyperreflexia.
27. Spinal cord lesions (above sixth thoracic
vertebrae)
Urodynamic-detrusor hyperreflexia, striated
sphincter dyssynergia, smooth sphincter
dyssynergia.
Autonomic dysreflexia-exaggerated sympathetic
response to any stimuli below level of lesion.
Inciting event-instrumentation of urinary bladder
or rectum.
Sweating, headache, hypertension, and reflex
bradycardia
28. Acute management of autonomic dysreflexia-
decompress rectum or bladder.
Parenteral ganglionic or adrenergic blocking
agents, such as chlorpromazine, may be
used.
Oral blocking agents, including terazosin,
may be used prophylactically
Spinal anesthetic before instrumentation.
29. Spinal cord lesions (below T6)
Urodynamic-detrusor hyperreflexia, striated
sphincter dyssynergia, and smooth sphincter
dyssynergia but no autonomic dysreflexia.
Incomplete bladder emptying secondary to
detrusor sphincter dyssynergia, or loss of
facilitatory input from higher centers.
Cornerstone of treatment involves CIC and
anticholinergic medications.
30. detrusor overactivity of the bladder
noted in 50% to 90% of patients with MS and
detrusor
areflexia in 20% to 30% of patients with MS
often noted during the
first 10 years following MS diagnosis and
tends to increase
as the patient’s level of disability worsens
31. Urinary incontinence is a common symptom
Urodynamic-detrusor overactivity, poor
bladder compliance, a fixed, obstructing
outlet that may be incompetent as well.
Risk of upper urinary tract damage
33. Detrusor hyperactivity with impaired bladder
contractility (DHIC)
Frequent but weak involuntary detrusor
contractions
Incontinence despite incomplete bladder
emptying
Associated with bladder trabeculation, slow
bladder contraction velocity, elevated urinary
residual volume after voiding attempts.
Seen in nursing home residents
34. Pelvic trauma, low myelomeningocele,
surgery
Both afferent and efferent neural connections
to bladder are lost
Failure to generate bladder contraction, loss
of bladder sensation
Urodynamic-normal capacity, compliant
bladder, nable to sense filling at any volume,
nable to generate any voiding contraction.
35. Tabes dorsalis, diabetes, syringomyelia
Poor bladder sensation
Allows bladder to distend without triggering a
reflex bladder contraction.
Gradual stretching of detrusor muscle-
detrusor failure, atonia
Urodynamics-large capacity, poorly sensitive
bladder and impaired bladder contractility
Painless urinary retention, overflow
incontinence and increased risk of UTI.
36. Herpetic infection, trauma, pelvic surgery,
lumbar spinal stenosis, lumbosacral
meningomyelocoele
Normal sensation of bladder filling but is
unable to generate detrusor pressure
sufficient to empty bladder.
Urodynamic -normal sensation and capacity,
no generation of voiding contractions.
Painful urinary retention or impaired bladder
emptying
40. Neuroanatomy, neurophysiology and
neuropharmacology of urinary bladder;
Continuum 2013;pg 7-20
Swaiman’s pediatric neurology: disorders of
micturition and defecation; pg 2157-2170.
Neurogenic Bladder; Peter T., Peter M.;
Advances in Urology;Volume 2012, Article ID
816274, 16 pages
The Epidemiology and Pathophysiology of
Neurogenic Bladder; David Ginsberg; Am J
Manag Care. 2013;19:S191-S196